Skip to content
DefDex

Federal award

STASON PHARMACEUTICALS, INC.

W81K0210P0119

Contract

Obligated and Ceiling

Obligated (net)
$123,908.50
Ceiling (potential value, not spending)
—
Current value
—
Gross positive obligations
$197,130.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
STASON PHARMACEUTICALS, INC. · T9M7KCTSZNL3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
STASON PHARMACEUTICALS, INC. · T9M7KCTSZNL3
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
Q301 · MEDICAL- LABORATORY TESTING
Industry (NAICS)
621511 · MEDICAL LABORATORIES
PIID
W81K0210P0119
Award type code
B
Actions
16 · Jul 20, 2010 to Jul 23, 2014
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History16

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 23, 2014FY2014P00015K−$53,382.50
—
Nov 21, 2013FY2014P00014C$37,360.00
—
Oct 3, 2013FY2014P00013B$0.00
—
Aug 22, 2013FY2013P00012B$0.00
—
Apr 4, 2013FY2013P00011M$0.00
—
Dec 5, 2012FY2013P00010B$0.00
—
Oct 24, 2012FY2013P00009C$56,535.00
—
Sep 11, 2012FY2012P00008G$0.00
—
Aug 14, 2012FY2012P00007B$19,175.00
—
Jan 5, 2012FY2012P00006M$0.00
—
Dec 15, 2011FY2012P00005C−$19,839.00
—
Nov 4, 2011FY2012P00004C$37,360.00
—
Sep 15, 2011FY2011P00003G$0.00
—
Oct 27, 2010FY2011P00002C$37,360.00
—
Sep 27, 2010FY2010P00001G$0.00
—
Jul 20, 2010FY20100—$9,340.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.